Advanced Therapy Showcase in Tokyo#1

  • twitter
  • Facebook
  • LINE

Click to open PDF

    ATST_flyer -Ver2-7 E.pdf

Life Science Innovation Network Japan (LINK-J) steps forward to launch a series of business partnering event “Advanced Therapy Showcase in Tokyo,” and is preparing for its first edition planned to be virtually held in Tokyo, Japan, on January 21, 2021.
The event features live-streaming plenary sessions, live-streaming company presentations, on-demand business pitches, and pre-arranged 1-on-1 business partnering meetings (1-on-1 meeting arrangements will open until February 17).
Any entities or individuals engaged in the field of advanced therapy, namely cell & gene therapy, regenerative medicine, etc., are encouraged to participate in the event to find suitable partner candidates for business development.

Date and Time

January 21, 2021 8:15-19:00




(Opens an external site)

Official language:English


Time Program

Keynotes by

  • Hideyuki Okano, M.D., Ph.D. (Chairman of the Board, LINK-J)
  • Steven A. Goldman, M.D., Ph.D.(Professor of Neurology and Neuroscience/ Co-Director, Center for Translational Neuromedicine /University of Rochester Medical Center and the /University of Copenhagen Faculty of Health and Medical Sciences)
  • Mr.Michael Lehmicke(Director, Science & Industry Affairs, ARM)
  • Takanori Takebe, M.D., Ph.D.(Professor, Institute of Research, Tokyo Medical and Dental University /Director, Communication Design Center, Yokohama City University /Director of Commercial Innovation, Center for Stem Cell and Organoid Medicine, Cincinnati Children's Hospital Medical Center /Assistant Professor, Division of Gastroenterology, Hepatology and Nutrition and Division of Developmental Biology, Cincinnati Children's Hospital Medical Center)
  • Yoshitsugu Shitaka, Ph.D.(Representative Director, Vice Chairperson FIRM,President of AIRM)

Live-streaming company presentation
(with a few breaks)

Exopharm Ltd
Glycostem Therapeutics B.V.
Terumo BCT, Inc.
Helixmith Co., Ltd
Eyestem Research Private Limited
TreeFrog Therapeutics
PDC*line pharma SA
Daiichi Sankyo Co., Ltd.
Salipro Biotech AB


Keynote by

  • Philippe Fauchet Owen Smith(4Bio Capital)
  • Nick Johnson, Ph.D., M.B.A.(Chief Strategy and Impact Officer Cell and Gene Therapy Catapult (CGTC))


Product developers, novel technology providers, platform developers, and researchers who seek partners in Japan or elsewhere, and crave to excel in the field of advanced therapies such as;

  • regenerative medicine and tissue engineering,
  • cell therapy and gene-modified cell therapy,
  • gene therapy (in vivo/ex vivo) and gene editing therapy,
  • exosome based therapy,
  • nucleic acid medicine,
  • stem cell based drug discovery, etc.

Participation fee

20,000 yen/person for LINK-J non-members
10,000 yen/person for LINK-J members
15,000 yen/person for members of the event supporters

Registration tiers

LINK-J members members of the event supporters LINK-J non-members
Tier 1: Live-streaming speakers
  • Entitled to give a real time live-streaming presentation for 20~30min (time is subject to change depending on the number of entries),
  • In case the number of applications exceeds the live-streaming capacity, the organizing committee may ask a certain number of applicants to move down to the “on-demand exhibitors” tier,
  • Eligible for 1-on-1 business meeting arrangements, and
  • Eligible to access the live-streaming presentations and the on-demand business pitch exhibitions.
10,000 yen/person 15,000 yen/person 20,000 yen/person
Tier 2: On-demand presenters
  • Entitled to post up business pitch exhibition materials ,
  • Eligible for 1-on-1 business meeting arrangements,
  • Eligible to access the live-streaming presentations on-demand business pitch exhibitions.
Tier 3: General attendees
  • Eligible for 1-on-1 business meeting arrangements, and
  • Eligible to access the live-streaming presentations and the on-demand business pitch exhibitions.

Registration deadline

Tier 1: Monday, November 30, 2020 JST
 →Extended to Friday, December 18, 2020 JST
Tier 2: Friday, January 8, 2021 JST
Tier 3:Friday, January 15, 2021 JST

List of Tier 3 participating companies (partial)

Mitsui Chemicals, Inc.
Otsuka Pharmaceutical Factory, Inc.
miibio, Inc.
SanBio Company Limited
Nippon Boehringer Ingelheim Co.,Ltd.
Daiichi Sankyo Co., Ltd.
Otsuka Pharmaceutical
Astellas Pharma Inc.
Santen Pharmaceutical Co., Ltd.
Fuji Chemical Industries Co.,Ltd.
Kyushu University Hospital
DyDo Pharma, inc.
Sumitomo Dainippon Pharma Co., Ltd.
Pharma Business Academy Ltd.
Johnson and Johnson INNOVATION
JCR Pharmaceuticals Co., Ltd.
Western Univ. JPRO
and more

Any information disclosed in live-streaming presentations and on-demand business-pitch post-ups shall be regarded as non-confidential.



Event Supporters

arm-logo-primary-color-lg.jpg biocom_logo_horiz_HiRes (2).jpg CGTC logo.png
Alliance for Regenerative Medicine(ARM) BIOCOM Cell & Gene Therapy Catapult
CCRM-LOGO-HORIZONTALwTAG.pngのサムネイル画像 LogoEurobiomedTraitbleu.png.jpgのサムネイル画像 FIRMロゴ決定稿(英記版).jpgのサムネイル画像
Centre for Commercialization of Regenerative Medicine(CCRM) Eurobiomed Forum for Innovative Regenerative Medicine (FIRM)
kobe.png JETRO_EN3.jpg kanagawa.pngのサムネイル画像
Foundation for Biomedical Research and Innovation at Kobe(FBRI) Japan External Trade Organization (JETRO) Kanagawa
Ftype_kawasaki.jpg KRP_logo_195.png MedCity_Master Logo_Colour_RGB (Transparent).png
Kawasaki Kyoto Research Park Corp. MedCity
Logo MEDICEN.PNG poster_yoko_png.png SwedenBIO.png
Medicen Paris Osaka SwedenBio